159 related articles for article (PubMed ID: 38794132)
1. An Assessment of Different Decision Support Software from the Perspective of Potential Drug-Drug Interactions in Patients with Chronic Kidney Diseases.
Bektay MY; Buker Cakir A; Gursu M; Kazancioglu R; Izzettin FV
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794132
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients.
Tecen-Yucel K; Bayraktar-Ekincioglu A; Yildirim T; Yilmaz SR; Demirkan K; Erdem Y
J Manag Care Spec Pharm; 2020 Oct; 26(10):1291-1296. PubMed ID: 32996393
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different decision support software programs in perspective of potential drug-drug interactions in the oncology clinic.
Bektay MY; Seker Z; Eke HK; Turk HM; Izzettin FV
J Oncol Pharm Pract; 2023 Jul; 29(5):1178-1186. PubMed ID: 35642275
[TBL] [Abstract][Full Text] [Related]
4. Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study.
Khanna J; Kumar S; Mehta S; Chaudhary J; Jain A
J Pharm Technol; 2024 Jun; 40(3):142-151. PubMed ID: 38784027
[No Abstract] [Full Text] [Related]
5. Prevalence of Potential Drug-Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital.
Santos-Díaz G; Pérez-Pico AM; Suárez-Santisteban MÁ; García-Bernalt V; Mayordomo R; Dorado P
Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32751436
[TBL] [Abstract][Full Text] [Related]
6. Preventing potential drug-drug interactions through alerting decision support systems: A clinical context based methodology.
Pirnejad H; Amiri P; Niazkhani Z; Shiva A; Makhdoomi K; Abkhiz S; van der Sijs H; Bal R
Int J Med Inform; 2019 Jul; 127():18-26. PubMed ID: 31128828
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
Shouqair TM; Rabbani SA; Sridhar SB; Kurian MT
Cureus; 2022 Apr; 14(4):e24019. PubMed ID: 35573572
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients.
Zhang J; Ma D; Chen M; Hu Y; Chen X; Chen J; Huang M; Dai H
Front Pharmacol; 2024; 15():1308260. PubMed ID: 38379901
[No Abstract] [Full Text] [Related]
9. Clinical relevancy and determinants of potential drug-drug interactions in chronic kidney disease patients: results from a retrospective analysis.
Saleem A; Masood I; Khan TM
Integr Pharm Res Pract; 2017; 6():71-77. PubMed ID: 29354553
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan.
Nusair MB; Al-Azzam SI; Arabyat RM; Amawi HA; Alzoubi KH; Rabah AA
Saudi Pharm J; 2020 Feb; 28(2):155-160. PubMed ID: 32042253
[TBL] [Abstract][Full Text] [Related]
11. Assessment of prescribed medications and pattern of distribution for potential drug-drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa.
Fasipe OJ; Akhideno PE; Nwaiwu O; Adelosoye AA
Clin Pharmacol; 2017; 9():125-132. PubMed ID: 29123429
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of potential drug-drug interactions in a public and private hospital among chronic kidney disease patients in Khyber Pakhtunkhwa: A retrospective cross-sectional study.
Zafar R; Rehman IU; Shah Y; Ming LC; Goh HP; Goh KW
PLoS One; 2023; 18(9):e0291417. PubMed ID: 37773947
[TBL] [Abstract][Full Text] [Related]
13. Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex
Abbas A; Al-Shaibi S; Sankaralingam S; Awaisu A; Kattezhathu VS; Wongwiwatthananukit S; Owusu YB
Int J Clin Pharm; 2022 Apr; 44(2):348-356. PubMed ID: 34811600
[TBL] [Abstract][Full Text] [Related]
14. Determination and comparison of potential drug-drug interactions using three different databases in northern cyprus community pharmacies.
Alkhalid ZN; Birand N
Niger J Clin Pract; 2022 Dec; 25(12):2005-2009. PubMed ID: 36537458
[TBL] [Abstract][Full Text] [Related]
15. Clinical decision support systems differ in their ability to identify clinically relevant drug interactions of immunosuppressants in kidney transplant patients.
Amkreutz J; Koch A; Buendgens L; Trautwein C; Eisert A
J Clin Pharm Ther; 2017 Jun; 42(3):276-285. PubMed ID: 28224645
[TBL] [Abstract][Full Text] [Related]
16. Assessment of drug interactions and their associated factors among patients with cardiovascular diseases: a cross-sectional study from the occupied Palestinian territory.
Al-Jabi SW; Aldabe L; Alhaj-Asaad L; Thaher M; Zyoud SH; Sweileh WM
Lancet; 2021 Jul; 398 Suppl 1():S8. PubMed ID: 34227990
[TBL] [Abstract][Full Text] [Related]
17. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
Noor S; Ismail M; Khadim F
Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
[TBL] [Abstract][Full Text] [Related]
18. The Prevalence and Severity of Potential Drug-Drug Interactions in Internal Medicine Ward at Soba Teaching Hospital.
Hamadouk RM; Alshareif EM; Hamad HM; Yousef BA
Drug Healthc Patient Saf; 2023; 15():149-157. PubMed ID: 37933264
[TBL] [Abstract][Full Text] [Related]
19. Potential drug-drug interactions in patients with non-small cell lung cancer at a university hospital in Turkey.
Albayrak A; Düzenli T; Kayıkçıoğlu E
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9621-9627. PubMed ID: 37222813
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Potential Drug-drug Interactions (pDDIs) and Their Risk Factors Among Hospitalized Cardiac Patients in a Tertiary-care Center of Central India: A Retrospective Record-based Study.
Sahoo AK; Singh A; Gupta D; Dhaneria S; Arunima P
Hosp Pharm; 2024 Feb; 59(1):24-31. PubMed ID: 38223855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
